Profile data is unavailable for this security.
About the company
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Company’s products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndrome’76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.
- Revenue in CNY (TTM)222.19m
- Net income in CNY150.81m
- Incorporated1981
- Employees491.00
- LocationShanghai Hile Bio-Technology Co LtdNo. 6720Jinhai Highway, Fengxian DistrictSHANGHAI 200021ChinaCHN
- Phone+86 2 160890892
- Fax+86 2 160890800
- Websitehttp://www.hile-bio.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 5.02bn | 404.00 | 18.84 | 2.52 | -- | 8.02 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.43bn | 117.53m | 5.03bn | 584.00 | 41.65 | 2.77 | -- | 3.51 | 0.7061 | 0.7061 | 8.61 | 10.60 | 0.6264 | 1.66 | 4.42 | 2,451,945.00 | 6.11 | 5.31 | 7.69 | 6.76 | 82.35 | 86.02 | 9.76 | 8.10 | 3.25 | -- | 0.0809 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.63bn | 193.23m | 5.05bn | 1.69k | 25.95 | 3.29 | -- | 3.10 | 0.4428 | 0.4428 | 3.72 | 3.49 | 0.5227 | 1.48 | 6.56 | 966,866.90 | 5.93 | 5.39 | 9.72 | 9.37 | 67.75 | 66.91 | 11.34 | 8.95 | 0.5527 | 16.41 | 0.3447 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
| GemPharmatech Co Ltd | 584.83m | 154.23m | 5.06bn | 1.34k | 32.80 | 2.43 | -- | 8.65 | 0.3762 | 0.3762 | 1.43 | 5.08 | 0.2501 | 3.78 | 2.48 | 435,790.40 | 6.60 | -- | 7.40 | -- | 68.05 | -- | 26.37 | -- | 5.12 | -- | 0.0553 | -- | 31.17 | -- | 31.79 | -- | -- | -- |
| Shanghai Haixin Group Co Ltd | 1.18bn | 166.03m | 5.06bn | 760.00 | 40.43 | 1.69 | -- | 4.28 | 0.1375 | 0.1375 | 0.9797 | 3.28 | 0.2403 | 7.43 | 8.13 | 1,556,014.00 | 3.90 | 2.68 | 4.42 | 3.06 | 45.07 | 44.55 | 16.24 | 11.17 | 2.75 | -- | 0.0209 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
| HitGen Inc | 409.13m | 64.05m | 5.20bn | 452.00 | 81.47 | 3.77 | -- | 12.71 | 0.1593 | 0.1593 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 784.35m | 254.48m | 5.34bn | 1.05k | 13.09 | 2.39 | -- | 6.80 | 2.02 | 2.02 | 4.01 | 11.04 | 0.2601 | 0.9453 | 7.66 | -- | 8.44 | 10.04 | 10.25 | 11.63 | 81.59 | 83.62 | 32.44 | 28.29 | 2.82 | -- | 0.2563 | -- | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | -- |
| Shanghai Hile Bio-Technology Co Ltd | 222.19m | 150.81m | 5.35bn | 491.00 | 35.14 | 4.52 | -- | 24.07 | 0.2313 | 0.2313 | 0.3395 | 1.80 | 0.1252 | 1.03 | 1.69 | 452,535.50 | 7.61 | 0.9734 | 9.69 | 1.43 | 47.65 | 51.66 | 60.74 | 5.84 | 1.33 | -- | 0.0295 | 22.73 | -13.62 | -0.2421 | 125.80 | 1.35 | -25.43 | 0.6107 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 932.29m | 102.57m | 5.53bn | 1.67k | 53.89 | 1.49 | -- | 5.93 | 0.2421 | 0.2421 | 2.20 | 8.75 | 0.211 | 0.8407 | 26.50 | 558,590.60 | 2.32 | -- | 2.74 | -- | 85.48 | -- | 10.98 | -- | 3.44 | -- | 0.0949 | -- | -18.12 | -- | -44.15 | -- | -- | -- |
| Shandong Lukang Pharmaceutical Co Ltd | 6.28bn | 267.79m | 5.53bn | 6.48k | 21.13 | 1.50 | -- | 0.881 | 0.292 | 0.292 | 6.88 | 4.11 | 0.7187 | 3.54 | 6.45 | 967,865.70 | 3.21 | 2.21 | 5.51 | 4.05 | 23.55 | 23.41 | 4.47 | 3.46 | 0.7313 | 5.39 | 0.4689 | 31.79 | 9.34 | 13.04 | 78.37 | 8.81 | -16.95 | 23.94 |
| Zhejiang Orient Gene Biotech Co Ltd | 1.56bn | -1.06bn | 5.60bn | 2.83k | -- | 0.7194 | -- | 3.58 | -5.25 | -5.25 | 7.75 | 38.59 | 0.1544 | 1.53 | 3.84 | 552,067.60 | -10.44 | 47.30 | -12.07 | 63.19 | 19.83 | 60.90 | -67.60 | 38.76 | 7.40 | -- | 0.0812 | 18.23 | -13.78 | 108.18 | -57.97 | 128.28 | 139.38 | -- |
| InventisBio Co Ltd | 127.17m | -339.74m | 5.60bn | 222.00 | -- | 2.76 | -- | 44.03 | -0.5909 | -0.5909 | 0.2212 | 3.52 | 0.055 | -- | 2.97 | 572,837.00 | -14.69 | -- | -15.63 | -- | 99.92 | -- | -267.16 | -- | -- | -- | 0.017 | -- | -- | -- | -35.09 | -- | -- | -- |
Data as of Apr 18 2024. Currency figures normalised to Shanghai Hile Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 6.19m | 0.96% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 2.28m | 0.36% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.32m | 0.20% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.27m | 0.20% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 972.80k | 0.15% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 625.60k | 0.10% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2023 | 609.30k | 0.10% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 465.80k | 0.07% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 248.10k | 0.04% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2023 | 235.70k | 0.04% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
